Aemcolo

Active Ingredient(s): Rifamycin
FDA Approved: * November 16, 2018
Pharm Company: * COSMO TECHNOLOGIES LTD
Category: Antibiotics

The rifamycins are a group of antibiotics that are synthesized either naturally by the bacterium Amycolatopsis rifamycinica or artificially. They are a subclass of the larger family of ansamycins. Rifamycins are particularly effective against mycobacteria, and are therefore used to treat tuberculosis, leprosy, and mycobacterium avium complex (MAC) infections. The rifamycin group includes the "classic" rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, r... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Aemcolo 194 mg Oral Tablet, Delayed Release
NDC: 57841-1200
Labeler:
Redhill Biopharma Ltd
Aemcolo 194 mg Oral Tablet, Delayed Release
NDC: 57841-1201
Labeler:
Redhill Biopharma Ltd
Aemcolo 194 mg Oral Tablet, Delayed Release
NDC: 71068-001
Labeler:
Aries Pharmaceuticals Inc